Neuroscience Letters 2001-01-12

Vasoactive intestinal peptide-stimulated adenosine 3',5'-cyclic monophosphate formation in cerebral cortex and hypothalamus of chick and rat: comparison of the chicken and mammalian peptide.

J Z Nowak, K Kuba

Index: Neurosci. Lett. 297(2) , 93-6, (2001)

Full Text: HTML

Abstract

Chicken and mammalian (human/porcine/rat) vasoactive intestinal peptides (VIP; 0.01-3 microM), whose structures differ by four amino acid residues in 11, 13, 26 and 28 positions, were compared with respect to their ability to stimulate adenosine 3',5'-cyclic monophosphate (cyclic AMP) formation in the hypothalamus and cerebral cortex of chick and rat. In four tested biological systems, the chicken VIP appeared to be significantly more potent in evoking cyclic AMP response than its mammalian counterpart, the differences were more pronounced in the chick tissues, particularly in the hypothalamus, where the mammalian peptide produced only weak (but significant) effect at the highest used dose, i.e. 3 microM. Pituitary adenylate cyclase-activating polypeptide, a VIP-like peptide, applied as a reference drug at 0.1 microM, strongly stimulated cyclic AMP formation in all tested systems. The data demonstrate significant quantitative differences in biological activity between mammalian and non-mammalian peptides tested in brain tissue of chicks and rats, indicating that usage of the mammalian VIP in at least 'avian' studies may lead to some false conclusions.


Related Compounds

  • VIP Antagonist
  • VIP (human, mouse...

Related Articles:

VIP boosts regulatory T cell induction by trophoblast cells in an in vitro model of trophoblast-maternal leukocyte interaction.

2015-07-01

[J. Leukoc. Biol. 98 , 49-58, (2015)]

Glucagon-like peptides 1 and 2 and vasoactive intestinal peptide are neuroprotective on cultured and mast cell co-cultured rat myenteric neurons.

2012-01-01

[BMC Gastroenterol. 12 , 30, (2012)]

Vasoactive intestinal polypeptide antagonists attenuate vagally induced tachycardia in the anesthetized dog.

1995-10-01

[Am. J. Physiol. 269(4 Pt 2) , H1467-72, (1995)]

Inhibition of human neuroblastoma growth by a specific VIP antagonist.

1994-01-01

[J. Mol. Neurosci. 5(4) , 231-9, (1994)]

A vasoactive intestinal peptide antagonist inhibits the growth of glioblastoma cells.

2001-12-01

[J. Mol. Neurosci. 17(3) , 331-9, (2001)]

More Articles...